A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression
Public ClinicalTrials.gov record NCT03228394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the Safety, Pharmacokinetics and Efficacy of IV Administration of Ganaxolone in Women with Postpartum Depression
Study identification
- NCT ID
- NCT03228394
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2017 (Actual)
- Primary completion
- May 10, 2019 (Actual)
- Completion
- May 10, 2020 (Actual)
- Last update posted
- Jul 19, 2023
2017 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Marinus Research Site | Little Rock | Arkansas | 72211 | — |
| Marinus Research Site | Costa Mesa | California | 92626 | — |
| Marinus Research Site | Lemon Grove | California | 91945 | — |
| Marinus Research Site | San Diego | California | 92103 | — |
| Marinus Research Site | Jacksonville | Florida | 32216 | — |
| Marinus Research Site | Atlanta | Georgia | 30331 | — |
| Marinus Research Site | Decatur | Georgia | 30030 | — |
| Marinus Research Site | Leawood | Kansas | 66206 | — |
| Marinus Research Site | Overland Park | Kansas | 66211 | — |
| Marinus Research Site | New York | New York | 10032 | — |
| Marinus Research Site | Dayton | Ohio | 45417 | — |
| Marinus Research Site | Houston | Texas | 77058 | — |
| Marinus Research Site | Irving | Texas | 75062 | — |
| Marinus Research Site | Orem | Utah | 84058 | — |
| Marinus Research Site | Salt Lake City | Utah | 84124 | — |
| Marinus Research Site | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03228394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03228394 live on ClinicalTrials.gov.